Journal article
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial
Abstract
BACKGROUND: Low-molecular-weight heparins and heparinoids are superior to unfractionated heparin in the prevention and treatment of venous thromboembolism, but their safety and efficacy in acute ischaemic stroke are inadequately defined.
METHODS: This randomised, double-blind, aspirin-controlled trial tested the safety and efficacy of treatment with high-dose tinzaparin (175 anti-Xa IU/kg daily; 487 patients), medium-dose tinzaparin (100 …
Authors
Investigators FTT; Bath PM; Lindenstrom E; Boysen G; De Deyn P; Friis P; Leys D; Marttila R; Olsson J-E; O'Neill D
Journal
The Lancet, Vol. 358, No. 9283, pp. 702–710
Publisher
Elsevier
Publication Date
9 2001
DOI
10.1016/s0140-6736(01)05837-8
ISSN
0140-6736